Skip to main content

Table 3 Patient distribution according to O′ Riordan et al. (2006) levels of eGFR (MDRD-4)

From: The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): a post-hoc between-sex analysis

 

Males

Females

Total

p-value

At transplant (ml/min/1.73m2)

 Level 1: eGFR ≥90

288 (57.3%)

65 (41.4%)

353 (53.5%)

0.0005a

 Level 2: eGFR 60–89

141 (28.0%)

56 (35.7%)

197 (29.8%)

 

 Level 3: eGFR 30–59

67 (13.3%)

29 (18.5%)

96 (14.5%)

 

 Level 4: eGFR 15–29

7 (1.4%)

4 (2.5%)

11 (1.7%)

 

 Level 5: eGFR < 15

0 (0.0%)

3 (1.9%)

3 (0.5%)

 

 Not Recorded

58

20

78

 

At inclusion visit (ml/min/1.73m2)

 Level 1: eGFR ≥90

156 (27.8%)

48 (27.1%)

204 (27.6%)

0.0299a

 Level 2: eGFR 60–89

277 (49.4%)

70 (39.6%)

347 (47.0%)

 

 Level 3: eGFR 30–59

117 (20.9%)

57 (32.2%)

174 (23.6%)

 

 Level 4: eGFR 15–29

5 (0.9%)

1 (0.6%)

6 (0.8%)

 

 Level 5: eGFR < 15

6 (1.1%)

1 (0.6%)

7 (1.0%)

 

At follow-up visit (ml/min/1.73m2)

 Level 1: eGFR ≥90

137 (24.4%)

39 (22.0%)

176 (23.9%)

0.25903b

 Level 2: eGFR 60–89

278 (49.6%)

78 (44.1%)

356 (48.2%)

 

 Level 3: eGFR 30–59

133 (23.7%)

54 (30.5%)

187 (25.3%)

 

 Level 4: eGFR 15–29

8 (1.4%)

5 (2.8%)

13 (1.8%)

 

 Level 5: eGFR < 15

5 (0.9%)

1 (0.6%)

6 (0.8%)

 
  1. eGFR estimated Glomerular Filtration Rate, MDRD-4 4 variable Modification of Diet in Renal Disease study equation
  2. aFisher exact test; bχ2 test